TLN-121 clinical trials

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

This study is testing a new medicine, TLN-121, for people with certain types of non-Hodgkin lymphoma that has come back or hasn't responded to other treatments. Doctors want to see if it's safe, how it works in the body, and if it can help shrink the cancer.